Hunan Jingfeng Pharmaceutical Co.,Ltd.’s Net Profit Dropped 85.8% in First Half of 2022

Hunan Jingfeng Pharmaceutical Co.,Ltd. (湖南景峰医药股份有限公司) (000908.SZ) reported a net profit of 12.2 million yuan in the first half of 2022, down 85.8% year-on-year.

Meanwhile, the company posted 402 million yuan in revenue, up 28.2% year-on-year.

At the end of the reporting period, it had 1.7 billion yuan in total assets and 1.3 billion yuan in total liabilities, with a liability-to-asset ratio of 79.8%.